Literature DB >> 19027780

SCN5A channelopathies--an update on mutations and mechanisms.

Thomas Zimmer1, Ralf Surber.   

Abstract

Voltage-gated Na+ channels mediate the rapid upstroke of the action potential in excitable tissues. Na(v)1.5, encoded by the SCN5A gene, is the predominant isoform in the heart. Mutations in SCN5A are associated with distinct cardiac excitation disorders often resulting in life-threatening arrhythmias. This review outlines the currently known SCN5A mutations linked to three distinct cardiac rhythm disorders: long QT syndrome subtype 3 (LQT3), Brugada syndrome (BS), and cardiac conduction disease (CCD). Electrophysiological properties of the mutant channels are summarized and discussed in terms of Na+ channel structure-function relationships and regarding molecular mechanisms underlying the respective cardiac dysfunction. Possible reasons for less convincing genotype-phenotype correlations are suggested.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027780     DOI: 10.1016/j.pbiomolbio.2008.10.005

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  68 in total

1.  Crystal structure of the ternary complex of a NaV C-terminal domain, a fibroblast growth factor homologous factor, and calmodulin.

Authors:  Chaojian Wang; Ben C Chung; Haidun Yan; Seok-Yong Lee; Geoffrey S Pitt
Journal:  Structure       Date:  2012-06-14       Impact factor: 5.006

2.  First clinical manifestation of Brugada syndrome during pregnancy.

Authors:  Dirk Prochnau; Hans R Figulla; Ralf Surber
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-08-17

3.  A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief.

Authors:  Jun-Ho Lee; Chul-Kyu Park; Gang Chen; Qingjian Han; Rou-Gang Xie; Tong Liu; Ru-Rong Ji; Seok-Yong Lee
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 4.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 5.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

Review 6.  Cardiac sodium channel mutations: why so many phenotypes?

Authors:  Man Liu; Kai-Chien Yang; Samuel C Dudley
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

7.  Na(+) channel I-II loop mediates parallel genetic and phosphorylation-dependent gating changes.

Authors:  Donald M Bers; Anthony W Herren
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

8.  MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome.

Authors:  Susmita Chakrabarti; Xiaofen Wu; Zhaogang Yang; Ling Wu; Sandro L Yong; Cuntai Zhang; Keli Hu; Qing K Wang; Qiuyun Chen
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-02-18

9.  Multiple loss-of-function mechanisms contribute to SCN5A-related familial sick sinus syndrome.

Authors:  Junhong Gui; Tao Wang; Richard P O Jones; Dorothy Trump; Thomas Zimmer; Ming Lei
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

Review 10.  Cardiac sodium channelopathies.

Authors:  Ahmad S Amin; Alaleh Asghari-Roodsari; Hanno L Tan
Journal:  Pflugers Arch       Date:  2009-11-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.